| Lastest Insider Transactions Of Nurix Therapeutics, Inc. ( NRIX ) | |||||||||
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-09-02 | Sell | 5,787 | 25.76 | 149,072 | 2026-09-02 19:42:42 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-09-02 | Option Exercise | 5,787 | 8.72 | 50,463 | 2026-09-02 19:42:42 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2026-08-05 | Sell | 4,356 | 25.00 | 108,900 | 2026-08-05 18:59:04 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2026-08-05 | Option Exercise | 4,356 | 1.86 | 8,102 | 2026-08-05 18:59:04 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2026-08-04 | Sell | 4,111 | 24.36 | 100,142 | 2026-08-05 06:39:37 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2026-08-04 | Sell | 4,761 | 24.36 | 115,989 | 2026-08-04 21:41:21 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-08-03 | Sell | 16,589 | 23.05 | 382,358 | 2026-08-03 17:51:59 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-08-03 | Option Exercise | 5,787 | 8.72 | 50,463 | 2026-08-03 17:51:59 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2026-07-30 | Sell | 2,845 | 23.38 | 66,524 | 2026-07-30 17:58:55 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2026-07-30 | Option Exercise | 10,180 | 0.00 | 0 | 2026-07-30 17:58:55 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-07-30 | Sell | 3,847 | 23.38 | 89,954 | 2026-07-30 17:56:08 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-07-30 | Option Exercise | 10,180 | 0.00 | 0 | 2026-07-30 17:56:08 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2026-07-30 | Sell | 3,847 | 23.38 | 89,954 | 2026-07-30 17:50:22 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2026-07-30 | Option Exercise | 10,180 | 0.00 | 0 | 2026-07-30 17:50:22 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-07-02 | Sell | 11,008 | 23.56 | 259,366 | 2026-07-02 18:02:59 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-07-02 | Option Exercise | 11,008 | 5.47 | 60,174 | 2026-07-02 18:02:59 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2026-06-25 | Sell | 5,394 | 20.00 | 107,880 | 2026-06-25 18:49:10 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-06-25 | Sell | 28,935 | 20.06 | 580,506 | 2026-06-25 18:38:05 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-06-25 | Option Exercise | 28,935 | 8.05 | 232,847 | 2026-06-25 18:38:05 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-06-02 | Sell | 8,148 | 16.60 | 135,253 | 2026-06-02 19:14:20 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-06-02 | Option Exercise | 3,422 | 1.86 | 6,365 | 2026-06-02 19:14:20 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2026-05-05 | Sell | 14,055 | 16.60 | 233,319 | 2026-05-05 19:53:41 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-05-04 | Sell | 8,148 | 16.96 | 138,210 | 2026-05-04 18:10:30 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-05-01 | Sell | 5,394 | 16.76 | 90,407 | 2026-05-01 17:50:20 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2026-04-30 | Sell | 2,388 | 16.65 | 39,749 | 2026-04-30 17:38:22 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2026-04-30 | Option Exercise | 8,608 | 0.00 | 0 | 2026-04-30 17:38:22 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-04-30 | Sell | 3,214 | 16.65 | 53,498 | 2026-04-30 17:37:50 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-04-30 | Option Exercise | 8,608 | 0.00 | 0 | 2026-04-30 17:37:50 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2026-04-30 | Sell | 3,214 | 16.65 | 53,498 | 2026-04-30 17:35:55 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2026-04-30 | Option Exercise | 8,608 | 0.00 | 0 | 2026-04-30 17:35:55 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-04-02 | Sell | 8,148 | 15.24 | 124,149 | 2026-04-02 19:02:16 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-03-02 | Sell | 8,148 | 15.44 | 125,793 | 2026-03-02 19:05:28 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-02-09 | Sell | 14,261 | 16.66 | 237,618 | 2026-02-09 19:47:50 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2026-02-03 | Option Exercise | 31,333 | 0.84 | 26,320 | 2026-02-03 21:12:37 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2026-01-30 | Sell | 3,661 | 16.60 | 60,767 | 2026-01-30 20:39:35 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2026-01-30 | Option Exercise | 11,496 | 0.00 | 0 | 2026-01-30 20:39:35 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-01-30 | Sell | 4,421 | 16.60 | 73,381 | 2026-01-30 20:38:30 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-01-30 | Option Exercise | 10,534 | 0.00 | 0 | 2026-01-30 20:38:30 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2026-01-30 | Sell | 4,895 | 16.60 | 81,249 | 2026-01-30 20:36:55 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2026-01-30 | Option Exercise | 11,816 | 0.00 | 0 | 2026-01-30 20:36:55 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-01-20 | Sell | 3,760 | 18.42 | 69,273 | 2026-01-20 19:57:57 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-01-20 | Option Exercise | 3,760 | 1.86 | 6,994 | 2026-01-20 19:57:57 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-01-20 | Sell | 3,760 | 18.42 | 69,273 | 2026-01-20 19:57:57 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2026-01-20 | Option Exercise | 3,760 | 1.86 | 6,994 | 2026-01-20 19:57:57 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2025-12-18 | Sell | 3,760 | 17.90 | 67,314 | 2025-12-18 18:08:18 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2025-12-18 | Option Exercise | 3,760 | 1.86 | 6,994 | 2025-12-18 18:08:18 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2025-11-24 | Sell | 37,600 | 17.07 | 641,697 | 2025-11-24 18:06:28 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2025-11-24 | Option Exercise | 37,600 | 1.86 | 69,936 | 2025-11-24 18:06:28 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2025-11-03 | Sell | 6,284 | 12.56 | 78,931 | 2025-11-03 19:14:23 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2025-10-30 | Sell | 3,130 | 12.80 | 40,054 | 2025-10-30 18:06:55 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2025-10-30 | Option Exercise | 11,494 | 0.00 | 0 | 2025-10-30 18:06:55 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2025-10-30 | Sell | 3,644 | 12.80 | 46,631 | 2025-10-30 18:02:29 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2025-10-30 | Option Exercise | 10,532 | 0.00 | 0 | 2025-10-30 18:02:29 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2025-10-30 | Sell | 4,087 | 12.80 | 52,300 | 2025-10-30 18:01:02 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2025-10-30 | Option Exercise | 11,815 | 0.00 | 0 | 2025-10-30 18:01:02 |
| NRIX | Nurix Therapeutics, Inc. | GREGORY JULIA P | Directior | 2025-09-17 | Option Exercise | 10,750 | 1.86 | 19,995 | 2025-09-17 18:58:07 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2025-08-01 | Sell | 5,402 | 11.03 | 59,598 | 2025-08-01 17:09:02 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2025-07-30 | Sell | 4,304 | 12.01 | 51,695 | 2025-07-30 18:49:09 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2025-07-30 | Option Exercise | 11,494 | 0.00 | 0 | 2025-07-30 18:49:09 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2025-07-30 | Sell | 3,841 | 12.01 | 46,134 | 2025-07-30 18:49:02 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2025-07-30 | Option Exercise | 10,532 | 0.00 | 0 | 2025-07-30 18:49:02 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2025-07-30 | Sell | 4,308 | 12.01 | 51,743 | 2025-07-30 18:48:55 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2025-07-30 | Option Exercise | 11,815 | 0.00 | 0 | 2025-07-30 18:48:55 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2025-05-02 | Sell | 6,198 | 11.33 | 70,243 | 2025-05-02 18:18:47 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2025-04-30 | Sell | 3,377 | 11.50 | 38,841 | 2025-04-30 19:35:40 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2025-04-30 | Option Exercise | 8,956 | 0.00 | 0 | 2025-04-30 19:35:40 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2025-04-30 | Sell | 2,894 | 11.50 | 33,286 | 2025-04-30 19:35:28 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2025-04-30 | Option Exercise | 7,674 | 0.00 | 0 | 2025-04-30 19:35:28 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2025-04-30 | Sell | 2,438 | 11.50 | 28,041 | 2025-04-30 19:35:19 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2025-04-30 | Option Exercise | 8,636 | 0.00 | 0 | 2025-04-30 19:35:19 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2025-03-03 | Sell | 5,825 | 14.49 | 84,388 | 2025-03-03 17:29:25 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2025-01-31 | Sell | 5,760 | 19.95 | 114,934 | 2025-02-03 20:03:45 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2025-01-31 | Option Exercise | 5,760 | 1.86 | 10,714 | 2025-02-03 20:03:45 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2025-01-30 | Sell | 3,220 | 19.85 | 63,929 | 2025-01-30 19:53:04 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2025-01-30 | Option Exercise | 7,674 | 0.00 | 0 | 2025-01-30 19:53:04 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2025-01-30 | Sell | 3,690 | 19.85 | 73,260 | 2025-01-30 19:48:14 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2025-01-30 | Option Exercise | 8,957 | 0.00 | 0 | 2025-01-30 19:48:14 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2025-01-30 | Sell | 2,811 | 19.85 | 55,809 | 2025-01-30 19:43:10 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2025-01-30 | Option Exercise | 8,636 | 0.00 | 0 | 2025-01-30 19:43:10 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2025-01-02 | Sell | 5,760 | 19.50 | 112,295 | 2025-01-02 17:28:52 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2025-01-02 | Option Exercise | 5,760 | 1.86 | 10,714 | 2025-01-02 17:28:52 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-12-02 | Sell | 5,760 | 21.73 | 125,155 | 2024-12-02 18:00:17 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-12-02 | Option Exercise | 5,760 | 1.86 | 10,714 | 2024-12-02 18:00:17 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-11-04 | Sell | 3,290 | 25.00 | 82,250 | 2024-11-04 17:48:03 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-11-04 | Option Exercise | 3,290 | 9.57 | 31,485 | 2024-11-04 17:48:03 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-11-01 | Sell | 5,760 | 24.28 | 139,867 | 2024-11-01 17:57:23 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-11-01 | Option Exercise | 5,760 | 1.86 | 10,714 | 2024-11-01 17:57:23 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-11-01 | Sell | 3,546 | 24.28 | 86,083 | 2024-11-01 17:57:13 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-10-30 | Sell | 2,368 | 24.30 | 57,554 | 2024-10-30 20:30:27 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-10-30 | Option Exercise | 8,636 | 0.00 | 0 | 2024-10-30 20:30:27 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2024-10-30 | Sell | 3,437 | 24.30 | 83,536 | 2024-10-30 20:30:17 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2024-10-30 | Option Exercise | 8,957 | 0.00 | 0 | 2024-10-30 20:30:17 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-10-30 | Option Exercise | 7,674 | 0.00 | 0 | 2024-10-30 20:30:07 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-10-30 | Sell | 4,182 | 24.30 | 101,644 | 2024-10-30 20:30:07 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-10-14 | Sell | 3,290 | 25.00 | 82,250 | 2024-10-15 09:16:24 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-10-14 | Option Exercise | 3,290 | 9.57 | 31,485 | 2024-10-15 09:16:24 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-10-01 | Sell | 5,760 | 22.23 | 128,017 | 2024-10-01 19:36:27 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-10-01 | Option Exercise | 5,760 | 1.86 | 10,714 | 2024-10-01 19:36:27 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-08-26 | Sell | 9,870 | 25.01 | 246,843 | 2024-08-26 18:23:34 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-08-26 | Option Exercise | 9,870 | 6.08 | 60,046 | 2024-08-26 18:23:34 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-07-01 | Sell | 5,760 | 20.81 | 119,837 | 2024-07-01 18:35:21 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-07-01 | Option Exercise | 5,760 | 1.86 | 10,714 | 2024-07-01 18:35:21 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-06-20 | Sell | 20,000 | 20.01 | 400,216 | 2024-06-20 16:58:20 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-06-13 | Sell | 1,864 | 17.02 | 31,721 | 2024-06-13 18:39:34 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-06-13 | Option Exercise | 1,864 | 1.86 | 3,467 | 2024-06-13 18:39:34 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-06-12 | Sell | 1,900 | 17.01 | 32,319 | 2024-06-12 19:30:50 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-06-12 | Option Exercise | 1,900 | 1.86 | 3,534 | 2024-06-12 19:30:50 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-06-05 | Sell | 400 | 17.00 | 6,801 | 2024-06-05 18:01:04 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-06-05 | Option Exercise | 400 | 1.86 | 744 | 2024-06-05 18:01:04 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-06-03 | Sell | 1,596 | 17.01 | 27,153 | 2024-06-03 18:36:17 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-06-03 | Option Exercise | 1,596 | 1.86 | 2,969 | 2024-06-03 18:36:17 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-05-02 | Sell | 3,499 | 12.83 | 44,878 | 2024-05-02 18:01:27 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-04-30 | Sell | 1,387 | 12.04 | 16,703 | 2024-04-30 18:33:33 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-04-30 | Option Exercise | 4,886 | 0.00 | 0 | 2024-04-30 18:33:33 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2024-04-30 | Sell | 2,007 | 12.04 | 24,169 | 2024-04-30 18:33:20 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2024-04-30 | Option Exercise | 5,206 | 0.00 | 0 | 2024-04-30 18:33:20 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-04-30 | Sell | 1,513 | 12.04 | 18,220 | 2024-04-30 18:33:06 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-04-30 | Option Exercise | 3,924 | 0.00 | 0 | 2024-04-30 18:33:06 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-02-16 | Sell | 6,812 | 10.02 | 68,223 | 2024-02-16 19:20:25 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-01-30 | Sell | 1,671 | 7.99 | 13,352 | 2024-01-30 18:53:11 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2024-01-30 | Option Exercise | 4,886 | 0.00 | 0 | 2024-01-30 18:53:11 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2024-01-30 | Sell | 2,334 | 7.99 | 18,649 | 2024-01-30 18:52:58 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2024-01-30 | Option Exercise | 5,207 | 0.00 | 0 | 2024-01-30 18:52:58 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-01-30 | Sell | 1,760 | 7.99 | 14,063 | 2024-01-30 18:52:46 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2024-01-30 | Option Exercise | 3,924 | 0.00 | 0 | 2024-01-30 18:52:46 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-12-20 | Sell | 3,541 | 10.00 | 35,421 | 2023-12-21 17:19:53 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-12-19 | Sell | 10,906 | 10.00 | 109,093 | 2023-12-20 16:55:24 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-10-30 | Sell | 1,080 | 5.20 | 5,613 | 2023-11-01 16:41:06 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-10-30 | Option Exercise | 4,886 | 0.00 | 0 | 2023-11-01 16:41:06 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2023-10-30 | Sell | 1,232 | 5.20 | 6,403 | 2023-11-01 16:40:52 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | Chief Legal Officer | 2023-10-30 | Option Exercise | 3,924 | 0.00 | 0 | 2023-11-01 16:40:52 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2023-10-30 | Sell | 1,633 | 5.20 | 8,487 | 2023-11-01 16:40:40 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2023-10-30 | Option Exercise | 5,207 | 0.00 | 0 | 2023-11-01 16:40:40 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-07-30 | Sell | 1,245 | 9.65 | 12,020 | 2023-08-01 16:28:39 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-07-30 | Option Exercise | 4,886 | 0.00 | 0 | 2023-08-01 16:28:39 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | General Counsel | 2023-07-30 | Sell | 1,420 | 9.65 | 13,710 | 2023-08-01 16:27:49 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | General Counsel | 2023-07-30 | Option Exercise | 3,924 | 0.00 | 0 | 2023-08-01 16:27:49 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2023-07-30 | Sell | 1,884 | 9.65 | 18,189 | 2023-08-01 16:26:17 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2023-07-30 | Option Exercise | 5,207 | 0.00 | 0 | 2023-08-01 16:26:17 |
| NRIX | Nurix Therapeutics, Inc. | Wolff Stefani | EVP and COO | 2023-04-30 | Sell | 342 | 9.88 | 3,378 | 2023-05-02 16:33:54 |
| NRIX | Nurix Therapeutics, Inc. | Wolff Stefani | EVP and COO | 2023-04-30 | Option Exercise | 962 | 0.00 | 0 | 2023-05-02 16:33:54 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-04-30 | Sell | 721 | 9.88 | 7,121 | 2023-05-02 16:33:07 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-04-30 | Option Exercise | 2,886 | 0.00 | 0 | 2023-05-02 16:33:07 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | General Counsel | 2023-04-30 | Sell | 682 | 9.88 | 6,736 | 2023-05-02 16:32:08 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | General Counsel | 2023-04-30 | Option Exercise | 1,924 | 0.00 | 0 | 2023-05-02 16:32:08 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2023-04-30 | Sell | 1,136 | 9.88 | 11,219 | 2023-05-02 16:31:19 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2023-04-30 | Option Exercise | 3,206 | 0.00 | 0 | 2023-05-02 16:31:19 |
| NRIX | Nurix Therapeutics, Inc. | Wolff Stefani | EVP and COO | 2023-01-30 | Sell | 424 | 11.78 | 4,995 | 2023-02-01 16:18:42 |
| NRIX | Nurix Therapeutics, Inc. | Wolff Stefani | EVP and COO | 2023-01-30 | Option Exercise | 962 | 0.00 | 0 | 2023-02-01 16:18:42 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-01-30 | Sell | 924 | 11.78 | 10,884 | 2023-02-01 16:17:47 |
| NRIX | Nurix Therapeutics, Inc. | van Houte Hans | Chief Financial Officer | 2023-01-30 | Option Exercise | 2,886 | 0.00 | 0 | 2023-02-01 16:17:47 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | General Counsel | 2023-01-30 | Sell | 848 | 11.78 | 9,989 | 2023-02-01 16:16:46 |
| NRIX | Nurix Therapeutics, Inc. | Ring Christine | General Counsel | 2023-01-30 | Option Exercise | 1,924 | 0.00 | 0 | 2023-02-01 16:16:46 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2023-01-30 | Sell | 1,412 | 11.78 | 16,633 | 2023-02-01 16:15:51 |
| NRIX | Nurix Therapeutics, Inc. | Hansen Gwenn | Chief Scientific Officer | 2023-01-30 | Option Exercise | 3,207 | 0.00 | 0 | 2023-02-01 16:15:51 |
